ANDERMAN TODD (Chief Legal Officer) sold 11.3% of their position (11.13K shares) of OCULAR THERAPEUTIX, INC on the open market
Open‑market sale worth $137.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/10/2025ACC: 0001104659-25-098706
Officer· Chief Legal Officer
Since Oct 2024
-11.13K
Net shares
Net seller
$137.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.13K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.13K
Price / share
$12.34
Trade value
$137.37K
% of position
11.3%
10/8/2025
98.70K→87.57K
Total
Net shares
−11.13K
Net value
-$137.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/8/2025 | S · Sale | −11.13K | $12.34 | $137.37K | 11.3% | 98.70K | 87.57K |
| Total | −11.13K | -$137.37K | ||||||
Derivative Transactions0
No derivative transactions reported